RN
Robert Nelsen
DELAYED 1 MONTH
10% Owner; Director, 10% Owner
Lyell Immunopharma, Inc.
Prime Medicine, Inc.
Sana Biotechnology, Inc.
Seaport Therapeutics, Inc.
Filings
4
Companies
4
Latest
Jun 5, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
—
Seaport Therapeutics, Inc.
Robert Nelsen
10% Owner
Purchase
$19.8M
1,100,000 sh
May 4 10:02 PM
May 4, 2026